Co-Morbidity between major depression and schizophrenia: Prevalence and clinical characteristics

Bener, Abdulbari; Dafeeah, Elnour Elnaem; Abou-Saleh, Mohammed T.; Bhugra, Dinesh; Ventriglio, Antonio

Co-Morbidity between major depression and schizophrenia: Prevalence and clinical characteristics

dc.authorid	0000-0002-7902-5803
dc.contributor.author	Bener, Abdulbari
dc.contributor.author	Dafeeah, Elnour Elnaem
dc.contributor.author	Abou-Saleh, Mohammed T.
dc.contributor.author	Bhugra, Dinesh
dc.contributor.author	Ventriglio, Antonio
dc.date.accessioned	2020-10-05T06:49:29Z
dc.date.available	2020-10-05T06:49:29Z
dc.date.issued	2020
dc.department	İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Halk Sağlığı Ana Bilim Dalı
dc.description.abstract	Backround: The aim of this study was to explore the co-morbidity between Major Depressive Disorder (MDD) and Schizophrenia (SZ) among a large number of patients describing their clinical characteristics and rate of prevalence.Subjects and methods: A cohort-study was carried out on 396 patients affected by MDD and SZ who consecutively attended the Department of Psychiatry, Rumeilah Hospital in Qatar. We employed the World Health Organization - Composite International Diagnostic Interview (WHO-CIDI) and the Structured Clinical Interview for DSM-5 (SCID-5) for diagnoses. Patients were also grouped in MDD patients with and without co-morbid SZ (MDD vs MDD/SZ) for comparisons.Results: A total of 396 subjects were interviewed. MDD patients with comorbid SZ (146(36.8%)) were 42.69 +/- 14.33 years old whereas MDD without SZ patients (250 (63.2%)) aged 41.59113.59. Statistically significant differences between MDD with SZ patients and MDD without SZ patients were: higher BMI (Body Mass Index) (p=0.025), lower family income (p=0.004), higher rate of cigarette smoking (p<0.001), and higher level of consanguinity (p=0.023). Also, statistically significant differences were found in General Health Score (p=0.017), Clinical Global Impression-BD Score (p=0.042), duration of illnesses (p=0.003), and Global Assessment of Functioning (p=0.012). Rates of anxiety dimensions (e.g.: general anxiety, agoraphobia, somatisation, etc.), mood dimensions (e.g.: major depression, mania, oppositional defiant behaviour, Bipolar disorder), Attention Deficit Hyperactivity Disorder, psychotic and personality dimensions were higher among MDD with SZ patients than MDD without SZ.Conclusion: This study confirms that MDD with SZ is a common comorbidity especially among patients reporting higher level of consanguinity. MDD/SZ comorbidity presents unfavourable clinical characteristics and higher levels of morbidity at rating scales.
dc.description.sponsorship	Qatar Diabetes Association, Qatar Foundation and partially Qatar National Research Fund-QNRF Hamad Medical Corporation	en_US
dc.identifier.citation	Bener, A., Dafeeah, E. E., Abou-Saleh, M. T., Bhugra, D. ve Ventriglio, A. (2020). Co-Morbidity between major depression and schizophrenia: Prevalence and clinical characteristics. Psychiatria Danubina, 32(1), 78-83. https://dx.doi.org/10.24869/psyd.2020.78
dc.identifier.doi	10.24869/psyd.2020.78
dc.identifier.endpage	83
dc.identifier.issn	0353-5053
dc.identifier.issue	1
dc.identifier.scopusquality	Q3
dc.identifier.startpage	78
dc.identifier.uri	https://dx.doi.org/10.24869/psyd.2020.78
dc.identifier.uri	https://hdl.handle.net/20.500.12511/5902
dc.identifier.volume	32
dc.identifier.wosquality	Q4
dc.indekslendigikaynak	Web of Science
dc.indekslendigikaynak	Scopus
dc.indekslendigikaynak	PubMed
dc.language.iso	en
dc.publisher	Medicinska Naklada
dc.relation.ispartof	Psychiatria Danubina	en_US
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Schizophrenia
dc.subject	Major Depressive Disorder
dc.subject	Co-Morbidity
dc.subject	Consanguinity
dc.title	Co-Morbidity between major depression and schizophrenia: Prevalence and clinical characteristics
dc.type	Article